Anyone who likes a good underdog story will want to keep their eye on Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) and GW Pharmaceuticals PLC (NASDAQ:GWPH) through this year and next as they launch their first products in the U.S. Smaller biotechs have a terrible track record when it comes to launching new drugs on their own, but most analysts expect these companies to buck the trend and propel their recently approved drugs to blockbuster status within a few years.
If the new U.S. sales teams these companies are forming meet the lofty expectations set before them, their shares would deliver some market-beating gains over the long run. If they put up an ordinary performance, though, investors could begin losing heavily in the quarters ahead. Let’s see if either of these biotech stocks is worth the risk.
Image source: Getty Images.
Best Biotech Stocks To Invest In Right Now: Glu Mobile Inc.(GLUU)
- [By Logan Wallace]
Glu Mobile Inc. (NASDAQ:GLUU) has received a consensus recommendation of “Buy” from the nine research firms that are presently covering the stock, MarketBeat.com reports. Three equities research analysts have rated the stock with a hold recommendation, five have given a buy recommendation and one has given a strong buy recommendation to the company. The average 1 year target price among brokerages that have covered the stock in the last year is $4.96.
- [By Logan Wallace]
Get a free copy of the Zacks research report on Glu Mobile (GLUU)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Keith Noonan]
Shares of Glu Mobile Inc. (NASDAQ:GLUU) stock dipped 16.8 % in July, according to data provided S&P Global Market Intelligence . Sell-offs hit the technology sector late last month on the heels of earnings reports from Facebook and Twitter that fell short of the market’s expectations.
- [By Rick Munarriz]
Tuesday was rough for Glu Mobile (NASDAQ:GLUU) investors. Shares of the mobile gaming company plunged 13% after it posted poorly received fourth-quarter results. It’s a big hit for one of the hottest mobile gaming stocks over the past couple of years, but it’s not much a setback when you stretch out your horizon beyond Tuesday’s trading day.
Best Biotech Stocks To Invest In Right Now: Stepan Company(SCL)
- [By Joseph Griffin]
Stepan (NYSE: SCL) and Unilever (NYSE:UN) are both basic materials companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, risk, profitability, dividends and earnings.
- [By Stephan Byrd]
Sociall (CURRENCY:SCL) traded down 8.5% against the US dollar during the 24-hour period ending at 0:00 AM E.T. on June 10th. During the last seven days, Sociall has traded 24.1% lower against the US dollar. Sociall has a total market capitalization of $2.31 million and $3,076.00 worth of Sociall was traded on exchanges in the last day. One Sociall token can now be purchased for approximately $0.14 or 0.00002034 BTC on cryptocurrency exchanges including HitBTC, Mercatox, Bancor Network and YoBit.
- [By Joseph Griffin]
Shawcor Ltd (TSE:SCL) – Investment analysts at Cormark decreased their FY2018 earnings per share (EPS) estimates for Shawcor in a report issued on Monday, August 13th. Cormark analyst J. Zhang now anticipates that the company will earn $0.47 per share for the year, down from their prior forecast of $0.49. Cormark also issued estimates for Shawcor’s Q2 2019 earnings at $0.32 EPS and FY2019 earnings at $1.43 EPS.
- [By Lisa Levin]
Shares of Stepan Company (NYSE: SCL) were down 14 percent to $76.53 as the company posted downbeat Q1 results.
Epizyme, Inc. (NASDAQ: EPZM) was down, falling around 14 percent to $13.125. Epizyme announced Monday after the close that the FDA issued a partial clinical hold on the U.S. enrollment of new patients in tazemetostat clinical trials.
- [By Ethan Ryder]
Shawcor Ltd (TSE:SCL) announced a quarterly dividend on Thursday, August 9th, Zacks reports. Shareholders of record on Monday, August 20th will be given a dividend of 0.15 per share on Friday, August 31st. This represents a $0.60 annualized dividend and a yield of 2.16%. The ex-dividend date of this dividend is Friday, August 17th.
- [By Lisa Levin] Companies Reporting Before The Bell
United Technologies Corporation (NYSE: UTX) is estimated to report quarterly earnings at $1.51 per share on revenue of $14.62 billion.
The Coca-Cola Company (NYSE: KO) is expected to report quarterly earnings at $0.46 per share on revenue of $7.31 billion.
Caterpillar Inc. (NYSE: CAT) is projected to report quarterly earnings at $2.07 per share on revenue of $11.93 billion.
Verizon Communications Inc. (NYSE: VZ) is expected to report quarterly earnings at $1.11 per share on revenue of $31.22 billion.
Lockheed Martin Corporation (NYSE: LMT) is estimated to report quarterly earnings at $3.42 per share on revenue of $11.28 billion.
The Sherwin-Williams Company (NYSE: SHW) is projected to report quarterly earnings at $3.15 per share on revenue of $3.94 billion.
Biogen Inc. (NASDAQ: BIIB) is expected to report quarterly earnings at $5.92 per share on revenue of $3.15 billion.
3M Company (NYSE: MMM) is estimated to report quarterly earnings at $2.52 per share on revenue of $8.26 billion.
JetBlue Airways Corporation (NASDAQ: JBLU) is projected to report quarterly earnings at $0.2 per share on revenue of $1.75 billion.
Eli Lilly and Company (NYSE: LLY) is expected to report quarterly earnings at $1.13 per share on revenue of $5.49 billion.
Harley-Davidson, Inc. (NYSE: HOG) is estimated to report quarterly earnings at $0.88 per share on revenue of $1.25 billion.
Corning Incorporated (NYSE: GLW) is expected to report quarterly earnings at $0.3 per share on revenue of $2.50 billion.
Centene Corporation (NYSE: CNC) is projected to report quarterly earnings at $1.88 per share on revenue of $13.28 billion.
The Travelers Companies, Inc. (NYSE: TRV) is estimated to report quarterly earnings at $2.77 per share on revenue of $6.75 billion.
Wipro Limited (NYSE: WIT) is expected to report quarterly earnings at $0.07 per share on revenue of $2.16 billion.
PACCAR Inc (NASDAQ: PCAR) is projected to
Best Biotech Stocks To Invest In Right Now: Newell Rubbermaid Inc.(NWL)
- [By Lisa Levin] Gainers
Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) shares rose 35.8 percent to $3.00.
Commercial Vehicle Group, Inc. (NASDAQ: CVGI) shares surged 32 percent to $8.94 after reporting upbeat Q1 earnings.
Carbon Black, Inc. (NASDAQ: CBLK) gained 29.6 percent to $24.62. Carbon Black priced its IPO at $19 per share.
California Resources Corporation (NYSE: CRC) shares rose 26.8 percent to $32.70 following upbeat Q1 earnings.
Pandora Media, Inc. (NYSE: P) gained 25 percent to $7.185 after reporting strong quarterly results.
Medifast, Inc. (NYSE: MED) shares climbed 23.7 percent to $122.87 after the company reported strong Q1 results and raised its FY18 guidance.
Natural Grocers by Vitamin Cottage, Inc. (NYSE: NGVC) rose 23.2 percent to $8.4999 after reporting Q2 results.
Portola Pharmaceuticals, Inc. (NASDAQ: PTLA) gained 22.2 percent to $41.27 after the FDA approved the company's Andexxa, the only antidote indicated for patients treated with rivaroxaban and apixaban.
Shake Shack Inc (NYSE: SHAK) rose 22.2 percent to $57.955 after the company reported upbeat results for its first quarter and raised its FY18 guidance.
Atomera Incorporated (NASDAQ: ATOM) jumped 19.7 percent to $6.12 after reporting Q1 results.
Super Micro Computer, Inc. (NASDAQ: SMCI) rose 16.4 percent to $21.00 after reporting strong preliminary results for the third quarter.
Titan International, Inc. (NYSE: TWI) shares rose 16.4 percent to $12.21 following Q1 earnings.
Integer Holdings Corporation (NYSE: ITGR) shares gained 14.9 percent to $63.75 following Q1 results.
Control4 Corporation (NASDAQ: CTRL) shares climbed 14.5 percent to $23.98 folloiwng strong Q1 results.
B&G Foods, Inc. (NYSE: BGS) climbed 12.6 percent to $25.40 after reporting Q1 earnings.
HMS Holdings Corp (NASDAQ: HMSY) shares gained 10 percent to $19.59 after reporting upbeat quarterly earnings.
Viavi Solutions Inc. (NASDAQ: VIAV) rose 7 percent to $10.09 following Q3 r
- [By ]
Rubbermaid parent Newell Brands Inc. (NWL) on Monday, April 23, reached its second agreement in recent months with an activist investor, this time agreeing to appoint two Starboard Value nominees to its board to end a proxy fight with plans to add an additional director mutually agreed upon between Starboard and rival activist Carl Icahn.
- [By Jamal Carnette, CFA]
Newell Brands (NYSE:NWL) is quickly becoming the textbook case of a failed merger. After acquiring Jarden Brands in 2015, the combined company failed to come together as a cohesive unit and many of the synergies never materialized. The result was an acrimonious public dispute between the founder of Jarden and Newell’s CEO, with both men working with activist investors to consolidate control.